Stereotaxis (NASDAQ:STXS) Director Fred A. Middleton sold 24,302 shares of the stock on the open market in a transaction dated Thursday, March 13th. The shares were sold at an average price of $4.21, for a total value of $102,311.42. Following the transaction, the director now directly owns 51,170 shares in the company, valued at approximately $215,426. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
Stereotaxis (NASDAQ:STXS) traded up 0.23% on Monday, hitting $4.43. The stock had a trading volume of 215,369 shares. Stereotaxis has a 52-week low of $1.104 and a 52-week high of $9.8996. The stock’s 50-day moving average is $5.09 and its 200-day moving average is $3.98. The company’s market cap is $76.4 million.
Stereotaxis (NASDAQ:STXS) last announced its earnings results on Tuesday, February 25th. The company reported ($0.19) EPS for the quarter. The company had revenue of $9.10 million for the quarter, compared to the consensus estimate of $12.20 million.
Stereotaxis, Inc designs, manufactures and markets cardiology instrument control system for use in a hospital’s interventional medical suite, or interventional lab, for the treatment of arrhythmias and coronary artery disease by enabling therapeutic solutions and improving catheter-based, or interventional, procedures.
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with Analyst Ratings Network's FREE daily email newsletter.